34 Monash University research projects have been awarded a combined total of more than $62.9 million in the latest National Health and Medical Research Council (NHMRC) Investigator Grants scheme.NHMRC Investigator Grants provide the highest-performin
WEST WARWICK — Before a room filled with their loved ones, more than two dozen members of the West Warwick Fire Department were honored this week during a promotional and
Two novel molecules to potentially combat asthma discovered
13
Researchers have discovered that giving L-tyrosine and PCS to mice prevents lung inflammation and an allergic asthma response.
A study on how the immune system impacts gut bacteria has led to the discovery of two molecules that can provide protection in experimental models of asthma and also substantially reduce the severity of an attack. The study was conducted at Monash University, Australia.
According to the researchers, neither of these molecules, one of which is already commercially available as a dietary supplement, were previously known to have an effect on asthma. The researchers found, through studying literature, that these metabolites are present in higher amounts in two studies of children without asthma compared to those with the disease.
Jan 25, 2021 11:00am Australian researchers found a protective effect of L-tyrosine and p-cresol sulfate in mouse asthma models as well as preclinical models of lung inflammation caused by COVID-19. (Pixabay)
One of the questions researchers have about the microbiome the population of bacteria that live in the gut is how it might be influenced by the immune system. A team of researchers from Monash University s Central Clinical School in Melbourne, Australia, set out to answer that question, and in the process found two molecules the scientists believe could offer new treatment strategies for asthma.
One of the molecules, L-tyrosine, is sold over the counter as a dietary supplement. So, the researchers plan to fast-track it into clinical trials. If it works, they believe it might also be used to treat acute respiratory distress syndrome (ARDS) in COVID-19 patients, they reported in the journal Nature Immunology.